Arena Pharma (ARNA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
Go back to Arena Pharma (ARNA) Tops Q1 EPS by 1c
May 9, 2016 4:06 PM EDT
SAN DIEGO, May 9, 2016 /PRNewswire/ --Â Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has appointed Amit D. Munshi as President, Chief Executive Officer and interim principal financial officer, effective May 11, 2016. Mr. Munshi will also join Arena's Board of Directors following Arena's 2016 annual stockholders' meeting, which is scheduled for June 13, 2016.
Mr. Munshi brings to Arena more than 25 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Harry F. Hixson, Jr., Ph.D., who has served as Arena's interim Chief Executive Officer and interim... More
May 9, 2016 4:05 PM EDT
SAN DIEGO, May 9, 2016 /PRNewswire/ --Â Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported financial results for the first quarter ended March 31, 2016, and provided a corporate update.
"We have continued to focus on the strategic priorities that we outlined last October, including advancing APD371 through Phase 1b and entering into a strategic collaboration with Boehringer Ingelheim that leverages our internally discovered compounds and validates the strength of our R&D platform," said Harry F. Hixson, Jr., Ph.D., Arena's interim Chief Executive Officer. "We are thrilled that... More
